This test is most useful if any of these apply to you.
Herpes is one of the most common infections in the world, and most people who carry it have never had a memorable outbreak. In United States sexually transmitted disease clinics, the large majority, 84.7%, of people who tested positive for the genital herpes virus had never been diagnosed with it.
This panel measures two separate long-lasting antibodies (called IgG, immune proteins that stay in your blood for life), one for each herpes virus. You learn not only whether you have been exposed but which virus you carry, and that distinction changes what your result means for your health, your partners, and any future pregnancy.
There are two herpes simplex viruses. Type 1 (called HSV-1) is the usual cause of cold sores around the mouth, though it increasingly causes genital infections too. Type 2 (HSV-2) is spread almost entirely through sexual contact and is the main cause of recurrent genital herpes.
Both tests look for antibodies to a viral protein called glycoprotein G, which is what lets the lab tell the two viruses apart rather than just reporting "herpes positive." These antibodies usually appear within 12 weeks of a new infection, with a typical midpoint around 25 days for type 1 and 21 days for type 2, and then they persist for the rest of your life.
The value of running both markers together is that a single test leaves the other virus unknown. Measured side by side, they sort you into one of four clear patterns, and each pattern carries a different conversation about transmission, recurrence, and risk.
| Result Pattern | What It Suggests |
|---|---|
| Type 1 positive, type 2 negative | Past HSV-1 infection, most often oral cold sores, but the test cannot confirm whether it is oral or genital. |
| Type 2 positive, type 1 negative | Past HSV-2 infection, which is almost always genital. This is the more decisive result. |
| Both positive | Prior exposure to both viruses, which does not necessarily mean two symptomatic diseases. |
| Both negative | No detectable antibodies. If exposure was recent, it may simply be too early, before the 12-week window closes. |
One caution applies to positive type 2 results near the cutoff. Labs report these as an index value, and low-positive numbers (roughly 1.1 to 3.0) are the least reliable, so a borderline positive is a reason to confirm rather than to conclude.
A confirmed positive type 2 result matters because carrying this virus is linked to a higher chance of catching HIV (the virus that causes AIDS) if exposed, roughly 2.7 times the risk in the general population, with no meaningful difference between men and women in the most recent pooled analysis. If your type 2 result is low-positive, ask for a second confirmatory test before accepting it, because false positives cluster near the cutoff.
If you currently have sores, a swab test of the lesion that detects the virus directly (called PCR) is more useful for that episode than antibodies. If you are negative but had a possible recent exposure, retest after the window period, allowing up to 12 weeks. If you are planning a pregnancy, your status is worth knowing early: a baby's risk of catching herpes is far higher when a mother is newly infected late in pregnancy (about 57%) than when she has long-standing genital herpes (about 2%).
One caveat on who should test: because these antibody tests throw off false positives in people at low risk, major guideline groups including the U.S. Preventive Services Task Force advise against blanket herpes screening of people who have no symptoms and no specific reason to check. This panel earns its place when you have a concrete reason, such as a partner with herpes, unexplained genital symptoms that were never swabbed, or a pregnancy you are planning.
Herpes 1 and 2 IgG Test is best interpreted alongside these tests.